ACOR

Acorda Therapeutics
ACOR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

15 hedge funds and large institutions have $2.35M invested in Acorda Therapeutics in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$17.7K
2
+$2.48K
3
+$1.12K
4
Bank of America
Bank of America
North Carolina
+$754
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$15

Top Sellers

1
-$25.5K
2
-$4.53K
3
-$2.26K
4
TRCT
Tower Research Capital (TRC)
New York
-$615
5
Osaic Holdings
Osaic Holdings
Arizona
-$15
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$801K
2
$691K
3
$489K
4
$163K
5
$100K
6
$56.5K
7
$35.5K
8
$4.5K
9
$4.36K
10
$754
11
$45
12
$44
13
$15
14
$15
15
–
16
–